Search

Author/Creator Lobo, Maurice

1. Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria. (September 2022)

Authors:
Larkin, James; Weber, Jeffrey; Del Vecchio, Michele; Gogas, Helen; Arance, Ana M.; Dalle, Stephane; Cowey, C. Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O.; Di Giacomo, Anna Marie; Middleton, Mark R.; De la Cruz-Merino, Luis; Arenberg...
Journal:
European journal of cancer
Issue:
Volume 173(2022)
Page Start:
285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial. Issue 11 (November 2020)

Authors:
Ascierto, Paolo A; Del Vecchio, Michele; Mandalá, Mario; Gogas, Helen; Arance, Ana M; Dalle, Stephane; Cowey, C Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O; Maio, Michele; Middleton, Mark R; de la Cruz-Merino, Luis; Arenberger, Petr;...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 11(2020)
Page Start:
1465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218). Issue 1 (23rd November 2020)

Authors:
Hodi, F. Stephen; Chapman, Paul B.; Sznol, Mario; Lao, Christopher D.; Gonzalez, Rene; Smylie, Michael; Daniels, Gregory A.; Thompson, John A.; Kudchadkar, Ragini; Sharfman, William; Atkins, Michael; Spigel, David R.; Pavlick, Anna; Monzon, Jose; Kim, Kevin B.; Ernst, Scott; Khushalani, Nikhil I....
Journal:
Melanoma research
Issue:
Volume 31:Issue 1(2021)
Page Start:
67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218). Issue 1 (February 2021)

Authors:
Hodi, F. Stephen; Chapman, Paul B.; Sznol, Mario; Lao, Christopher D.; Gonzalez, Rene; Smylie, Michael; Daniels, Gregory A.; Thompson, John A.; Kudchadkar, Ragini; Sharfman, William; Atkins, Michael; Spigel, David R.; Pavlick, Anna; Monzon, Jose; Kim, Kevin B.; Ernst, Scott; Khushalani, Nikhil I....
Journal:
Melanoma research
Issue:
Volume 31:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗